VOYA Investment Management
ACRS icon

VOYA Investment Management’s Aclaris Therapeutics ACRS Stock Holding History

VOYA Investment Management’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.2K Sell
16,311
-937
-5% -$3.16K ﹤0.01% 2258
2025
Q4 		$51.9K Hold
17,248
– – ﹤0.01% 2337
2025
Q3 		$32.8K Sell
17,248
-9,631
-36% -$16.8K ﹤0.01% 2417
2025
Q2 		$38.2K Buy
+26,879
New +$36.4K ﹤0.01% 2631
2023
Q4 		– Sell
-28,525
Closed -$195K – 2898
2023
Q3 		$195K Buy
28,525
+684
+2% +$5.84K ﹤0.01% 2559
2023
Q2 		$289K Sell
27,841
-78,915
-74% -$714K ﹤0.01% 2387
2023
Q1 		$864K Hold
106,756
– – ﹤0.01% 1738
2022
Q4 		$1.68M Hold
106,756
– – ﹤0.01% 1401
2022
Q3 		$1.68M Buy
106,756
+84,287
+375% +$1.33M ﹤0.01% 1394
2022
Q2 		$314K Buy
22,469
+2,461
+12% +$34.5K ﹤0.01% 2144
2022
Q1 		$345K Hold
20,008
– – ﹤0.01% 2113
2021
Q4 		$291K Buy
20,008
+265
+1% +$4.01K ﹤0.01% 2318
2021
Q3 		$355K Buy
19,743
+2,601
+15% +$41.7K ﹤0.01% 2246
2021
Q2 		$301K Buy
+17,142
New +$389K ﹤0.01% 2376
2020
Q2 		– Sell
-16,490
Closed -$17K – 2504
2020
Q1 		$17K Hold
16,490
– – ﹤0.01% 2596
2019
Q4 		$31K Buy
16,490
+2,303
+16% +$3.82K ﹤0.01% 2663
2019
Q3 		$15K Hold
14,187
– – ﹤0.01% 2547
2019
Q2 		$31K Hold
14,187
– – ﹤0.01% 2576
2019
Q1 		$85K Hold
14,187
– – ﹤0.01% 2453
2018
Q4 		$105K Buy
14,187
+2,846
+25% +$29.3K ﹤0.01% 2391
2018
Q3 		$165K Hold
11,341
– – ﹤0.01% 2395
2018
Q2 		$226K Buy
+11,341
New +$210K ﹤0.01% 2308
2018
Q1 		– Sell
-9,852
Closed -$243K – 2580
2017
Q4 		$243K Hold
9,852
– – ﹤0.01% 2247
2017
Q3 		$254K Buy
9,852
+762
+8% +$20.4K ﹤0.01% 2252
2017
Q2 		$247K Buy
+9,090
New +$247K ﹤0.01% 2286

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

VOYA Investment Management's ACRS Position: Q1 2026 in Review

VOYA Investment Management reduced its Aclaris Therapeutics (ACRS) stake by 5.4% in Q1 2026, selling an estimated $3.16K and leaving 16,311 shares worth $61.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

VOYA Investment Management first reported a position in ACRS in Q2 2017 and has held it in 25 quarters since. The position peaked at $1.68M in Q4 2022. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

  • VOYA Investment Management held 16,311 shares of Aclaris Therapeutics worth $61.2K as of Q1 2026.
  • VOYA Investment Management sold 937 Aclaris Therapeutics shares in Q1 2026, an estimated $3.16K.
  • Aclaris Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2258 holding.
  • VOYA Investment Management first reported a position in Aclaris Therapeutics in Q2 2017 and has held it in 25 quarters since.
  • VOYA Investment Management's Aclaris Therapeutics position peaked at $1.68M in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.